We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
(+9.5%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$516M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$253M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$210M |
| 4 |
Broadcom
AVGO
|
+$161M |
| 5 |
Uber
UBER
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$340M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$328M |
| 3 |
VMW
VMware, Inc
VMW
|
+$255M |
| 4 |
Chevron
CVX
|
+$187M |
| 5 |
lululemon athletica
LULU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.57% |
| 2 | Healthcare | 16.39% |
| 3 | Financials | 11.55% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
American Water Works
AWK
$26.8B
| $6.82M | 0.01% |
+51,633
| New | +$6.51M |
|
|
TERN
652
DELISTED
Terns Pharmaceuticals
TERN
| $6.81M | 0.01% |
1,050,000
+950,000
| +950% | +$5.02M |
|
653
Vulcan Materials
VMC
$36.5B
| $6.61M | 0.01% |
29,098
-78,000
| -73% | -$16.5M |
|
654
Crescent Energy
CRGY
$3.74B
| $6.61M | 0.01% |
500,000
| – | – |
|
655
Bio-Rad Laboratories Class A
BIO
$9.16B
| $6.56M | 0.01% |
20,310
+19,500
| +2,407% | +$6.11M |
|
656
Immatics
IMTX
$1.29B
| $6.54M | 0.01% |
621,500
+295,000
| +90% | +$2.72M |
|
657
Corebridge Financial
CRBG
$15.2B
| $6.5M | 0.01% |
+300,000
| New | +$6.19M |
|
658
Atlas Energy Solutions
AESI
$1.38B
| $6.46M | 0.01% |
375,000
+290,675
| +345% | +$5.35M |
|
|
AKRO
659
DELISTED
Akero Therapeutics
AKRO
| $6.42M | 0.01% |
275,000
-1,668,009
| -86% | -$32.9M |
|
660
Fate Therapeutics
FATE
$290M
| $6.36M | 0.01% |
+1,700,000
| New | +$4.01M |
|
|
MREO
661
Mereo BioPharma
MREO
$48.8M
| $6.12M | 0.01% |
2,650,000
+1,850,000
| +231% | +$3.54M |
|
662
FIVE9
FIVN
$2.17B
| $5.9M | 0.01% |
+75,000
| New | +$5.22M |
|
663
PACCAR
PCAR
$69.5B
| $5.85M | 0.01% |
+59,885
| New | +$5.38M |
|
664
Larimar Therapeutics
LRMR
$436M
| $5.81M | 0.01% |
1,276,680
+100,000
| +8% | +$337K |
|
|
XYZ
665
Block Inc
XYZ
$47B
| $5.8M | 0.01% |
+75,000
| New | +$4.24M |
|
666
Clarivate
CLVT
$1.18B
| $5.79M | 0.01% |
+625,000
| New | +$4.62M |
|
667
Teledyne Technologies
TDY
$31.9B
| $5.73M | 0.01% |
12,842
-48,216
| -79% | -$19.4M |
|
668
Toll Brothers
TOL
$14.1B
| $5.65M | 0.01% |
+55,000
| New | +$4.58M |
|
669
Manchester United
MANU
$3.78B
| $5.58M | 0.01% |
273,964
-100,000
| -27% | -$1.9M |
|
670
Teva Pharmaceuticals
TEVA
$40.6B
| $5.5M | 0.01% |
+527,000
| New | +$4.92M |
|
671
SentinelOne
S
$7.12B
| $5.49M | 0.01% |
200,000
+125,000
| +167% | +$2.42M |
|
672
Epsilon Energy
EPSN
$170M
| $5.39M | 0.01% |
1,061,909
+15,269
| +1% | +$81.5K |
|
673
Check Point Software Technologies
CHKP
$12.8B
| $5.35M | 0.01% |
+35,000
| New | +$4.94M |
|
674
Annovis Bio
ANVS
$79.1M
| $5.34M | 0.01% |
285,347
-14,653
| -5% | -$130K |
|
675
Maplebear
CART
$10.6B
| $5.28M | 0.01% |
+225,000
| New | +$5.66M |
|
Similar funds
Adage Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
- Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
- Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
- Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
- Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
- Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
- Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.
Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.